~~<i id='27998C16D3'><strike id='27998C16D3'><tt id='27998C16D3'><pre id='27998C16D3'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：leisure time 2025-10-04 08:07:45 Page View：8

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Psychedelics group wrestles with new pharma identity

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

4:07WirefenceisseenoutsideoftheFultonCountyJailafteraGrandJurybroughtbackindictmentsagainstformerpre

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Former Pear Therapeutics executives start new VC firm

SerialbiotechentrepreneurBobLangerwillserveasanadvisertoT.rxCapital.PatGreenhouse/GlobeStaffExecutiv